Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatmentWICHERS, Marieke C; KENIS, Gunter; LEUE, Carsten et al.Biological psychiatry (1969). 2006, Vol 60, Num 1, pp 77-79, issn 0006-3223, 3 p.Article

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject DrugsROBAEYS, Geert; GREBELY, Jason; WEDEMEYER, Heiner et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S129-S137, SUP2Article

Resource use and cost of hepatitis C-related careNEVENS, Frederik; COLLE, Isabelle; MICHIELSEN, Peter et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 10, pp 1191-1198, issn 0954-691X, 8 p.Article

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statementSCHAEFER, Martin; CAPURON, Lucile; FRIEBE, Astrid et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1379-1390, issn 0168-8278, 12 p.Article

Interferon-α-induced depressive symptoms are related to changes in the cytokine network but not to cortisolWICHERS, Marieke C; KENIS, Gunter; KOEK, Ger H et al.Journal of psychosomatic research. 2007, Vol 62, Num 2, pp 207-214, issn 0022-3999, 8 p.Article

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causesROBAEYS, Geert; VAN VLIERBERGHE, Hans; MATHEI, Catharina et al.European journal of gastroenterology & hepatology. 2006, Vol 18, Num 2, pp 159-166, issn 0954-691X, 8 p.Article